AARTIPHARM.NSAARTIPHARM.NSNSE
Loading
Operating Income ScalingExpanding
Percentile Rank100
3Y CAGR+31.8%
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

3Y CAGR
+31.8%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
2.3x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$3.77B+34.1%
2024$2.81B+0.7%
2023$2.80B+69.6%
2022$1.65B+3586388.1%
2021$-45960.00+75.4%
2020$-187000.00-